Butterfly Network, Inc. (BFLY): R&D Expense
$36.26M
Year ended 2025-12-31
$38.10M
Trailing 12 months to 2026-06-30
-25.6%
3-year compound annual growth
-6.1%
5-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $36.26M | -4.1% | 2026-02-27, From 2025-01-01 |
| 2024-12-31 | $37.80M | -32.0% | 2026-02-27, From 2024-01-01 |
| 2023-12-31 | $55.62M | -36.8% | 2026-02-27, From 2023-01-01 |
| 2022-12-31 | $88.04M | +18.2% | 2025-02-28, From 2022-01-01 |
| 2021-12-31 | $74.46M | +49.7% | 2024-03-04, From 2021-01-01 |
| 2020-12-31 | $49.74M | +1.6% | 2023-03-23, From 2020-01-01 |
| 2019-12-31 | $48.93M | n/a | 2022-03-28, From 2019-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Butterfly Network, Inc. (BFLY) | 2025-12-31 | $36.26M | -4.1% |
| Biolife Solutions Inc (BLFS) | 2025-12-31 | $7.57M | +59.3% |
| NeuroPace Inc (NPCE) | 2025-12-31 | $27.89M | +17.9% |
| Kestra Medical Technologies, Ltd. (KMTS) | 2026-04-30 | $19.48M | +24.5% |
| Beta Bionics, Inc. (BBNX) | 2025-12-31 | $34.79M | +32.9% |
| Sanara MedTech Inc. (SMTI) | 2025-12-31 | $5.07M | +79.3% |
| Pulmonx Corp (LUNG) | 2025-12-31 | $19.49M | +10.9% |
| Vaso Corp (VASO) | 2025-12-31 | $728.0K | -14.5% |
| Ceribell, Inc. (CBLL) | 2025-12-31 | $19.14M | +41.2% |
Compare BFLY, BLFS, NPCE, KMTS side by side · Screen every company in X-Ray Apparatus & Tubes & Related Irradiation Apparatus ↗